Clinical Trial Update: Studying the Treatment Effect of Pirfenidone in Chronic Lung Allograft Dysfunction (STOP-CLAD) [Phase 2]

View source ↗

Summary

Phase 2 trial studying pirfenidone for chronic lung allograft dysfunction in lung transplant recipients was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disorder Related to Lung Transplantation
• Lung Allograft Dysfunction

Drugs mentioned

• PIRFENIDONE (pirfenidone)

Snippet

Sponsor: University of Michigan | Conditions: Disorder Related to Lung Transplantation, Chronic Lung Allograft Dysfunction | Phase 2 | Status: TERMINATED | Results posted: 2022-08-17